TRIM15 and hepatocellular carcinoma: We demonstrated that the expression level of pAKT-S473, pFOXO1-S319, and TRIM15 were up-regulated in sorafenib resistant tumor samples from HCC patients compared to those in sorafenib sensitive group (Supplementary Fig. 6k).